Invirsa LLC
Invirsa LLC, based in Columbus, OH, develops innovative treatments targeting DNA damage-related ocular conditions, with its lead compound INV-102 showing promise in enhancing cellular stability and promoting effective DNA repair. The company is advancing its research with significant support from BARDA, focusing on conditions such as injuries from sulfur mustard gas and infectious conjunctivitis.
With a leadership team and scientific advisory board boasting extensive industry expertise, Invirsa aims to provide effective solutions for ocular health, particularly in addressing the unmet needs of viral and bacterial conjunctivitis. The company is committed to making INV-102 widely available nationwide, enhancing recovery outcomes and reducing the misuse of antibiotics.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.


